Slowing Down Myopia Progression with Contact Lenses - Everyday Cases from the Clinic.
Ana Paula Ribeiro ReisAnja M Palmowski-WolfeRalf BeuschelPublished in: Klinische Monatsblatter fur Augenheilkunde (2021)
Patients showed a slower myopia progression under MFCLs or OK, which supports their role as a treatment option in myopia management. In this regard, AL measurement is an important additional parameter to be included in the assessment of myopia progression in clinical practice. Identification of children at risk of developing high/pathologic myopia (family history, environmental risk factors) needs to improve so that the first stages of myopic shift can be recognized and targeted. Changes in lifestyle should be actively encouraged, especially when the impact of decreases in outdoor time secondary to COVID-19 is yet to become clear.
Keyphrases
- risk factors
- optic nerve
- end stage renal disease
- clinical practice
- coronavirus disease
- newly diagnosed
- sars cov
- ejection fraction
- chronic kidney disease
- prognostic factors
- metabolic syndrome
- peritoneal dialysis
- primary care
- air pollution
- neoadjuvant chemotherapy
- cardiovascular disease
- patient reported outcomes
- climate change
- drug delivery
- cancer therapy
- lymph node